Simon D Roger

Simon D Roger

UNVERIFIED PROFILE

Are you Simon D Roger?   Register this Author

Register author
Simon D Roger

Simon D Roger

Publications by authors named "Simon D Roger"

Are you Simon D Roger?   Register this Author

54Publications

1252Reads

8Profile Views

Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE.

Am J Nephrol 2019 28;50(6):473-480. Epub 2019 Oct 28.

Department of Cardiology, Saint Luke's Mid America Heart Institute and Department of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000504078DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947980PMC
October 2019

Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease.

Authors:
Simon D Roger

Clin Kidney J 2017 Dec 28;10(Suppl 1):i9-i15. Epub 2017 Nov 28.

Department of Renal Medicine, Gosford Hospital, Gosford, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ckj/sfx100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716159PMC
December 2017

Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis.

Perit Dial Int 2015 Jul-Aug;35(4):481-9. Epub 2014 Mar 1.

Takeda Development Center Americas, Deerfield, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3747/pdi.2012.00224DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520731PMC
May 2016

New data on the safety of IV iron-but why the discrepancy with FIND-CKD?

Kidney Int 2015 Dec;88(6):1445-1446

Department of Renal Medicine, Gosford Hospital, Gosford, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ki.2015.302DOI Listing
December 2015

Sodium zirconium cyclosilicate in hyperkalemia.

N Engl J Med 2015 Jan 21;372(3):222-31. Epub 2014 Nov 21.

From the Melbourne Renal Research Group, the Department of Medicine, University of Melbourne, and the Department of Nephrology, Royal Melbourne Hospital, Melbourne, VIC (D.K.P.), and Renal Research, Gosford, NSW (S.D.R.) - both in Australia; ZS Pharma, Coppell (H.S.R., B.S.), and the University of Texas Health Science Center at San Antonio (W.Q.) and Renal Associates (P.P.), San Antonio - all in Texas; Boston Biostatistics Research Foundation, Framingham, MA (P.T.L.); Academic Medical Research Institute, Los Angeles (M.A.E.-S.), and Apex Research, Riverside (B.S.) - both in California; and Denver Nephrologists, Denver, (G.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1411487DOI Listing
January 2015

ACEIs for cardiovascular risk reduction--have we taken our eye off the ball?

Aust Fam Physician 2013 Sep;42(9):634-8

BMed(Hons), MD, FRACP, FCSANZ, is a cardiologist and Director, Heart Failure Unit and Department of Cardiac Rehabilitation, Concord Hospital, New South Wales.

View Article

Download full-text PDF

Source
September 2013

Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfa.

Clin J Am Soc Nephrol 2013 Apr 14;8(4):538-45. Epub 2012 Dec 14.

Hofstra North Shore-Long Island Jewish School of Medicine, Great Neck, NY 11021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.03440412DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613947PMC
April 2013

A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients.

Nephrol Dial Transplant 2011 May 7;26(5):1599-607. Epub 2010 Oct 7.

Department of Medicine, University of Texas Health Science Centre and Texas Diabetes Institute, San Antonio, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfq613DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084440PMC
May 2011

Hypercalcaemia as a prodromal feature of indolent Pneumocystis jivorecii after renal transplantation.

Nephrol Dial Transplant 2011 May 4;26(5):1740-2. Epub 2011 Mar 4.

Department of Renal Medicine, Westmead Hospital, Sydney, Australia.

View Article

Download full-text PDF

Source
https://academic.oup.com/ndt/article-lookup/doi/10.1093/ndt/
Publisher Site
http://dx.doi.org/10.1093/ndt/gfr051DOI Listing
May 2011

Biosimilars: current status and future directions.

Authors:
Simon D Roger

Expert Opin Biol Ther 2010 Jul;10(7):1011-8

Renal Unit, Gosford Hospital, Holden Street, Gosford, 2250, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712591003796553DOI Listing
July 2010

Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial.

Nephrol Dial Transplant 2010 Mar 10;25(3):920-6. Epub 2009 Nov 10.

Department of Renal Medicine, Eastern Health, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfp584DOI Listing
March 2010

Longitudinal analysis of performance of estimated glomerular filtration rate as renal function declines in chronic kidney disease.

Nephrol Dial Transplant 2009 Jan 28;24(1):109-16. Epub 2008 Aug 28.

1Department of Nephrology, Western Hospital, Melbourne, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfn477DOI Listing
January 2009

Biosimilars: opportunity or cause for concern?

J Pharm Pharm Sci 2007 ;10(3):405-10

Department of Renal Medicine, Gosford Hospital, Australia.

View Article

Download full-text PDF

Source
October 2007

Understanding epoetin use: databases or clinical trials?

Authors:
Simon D Roger

Nephrology (Carlton) 2007 Apr;12(2):118-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1797.2007.00768.xDOI Listing
April 2007

Epoetin trials: randomised controlled trials don't always mimic observational data.

Nephrol Dial Transplant 2007 Mar 8;22(3):684-6. Epub 2007 Jan 8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfl740DOI Listing
March 2007

Chronic kidney disease, anemia, and epoetin.

Authors:
Simon D Roger

N Engl J Med 2007 Mar;356(9):958; author reply 958-9

View Article

Download full-text PDF

Source
March 2007

Proton pump inhibitors: indigestion for nephrologists!

Authors:
Simon D Roger

Nephrology (Carlton) 2006 Oct;11(5):379-80

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1797.2006.00675.xDOI Listing
October 2006

Implementing iron management clinical practice guidelines in patients with chronic kidney disease having dialysis.

Med J Aust 2006 Sep;185(6):310-4

Centre for Kidney Research, The Children's Hospital at Westmead, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
September 2006

Biosimilars: how similar or dissimilar are they?

Authors:
Simon D Roger

Nephrology (Carlton) 2006 Aug;11(4):341-6

Renal Unit, Gosford Hospital, Gosford, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1440-1797.2006.00594.x
Publisher Site
http://dx.doi.org/10.1111/j.1440-1797.2006.00594.xDOI Listing
August 2006

Proton pump inhibitors and acute interstitial nephritis.

Clin Gastroenterol Hepatol 2006 May;4(5):597-604

University of Sydney, Sydney, and Department of Medicine, Manly Hospital, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2005.11.004DOI Listing
May 2006

Effect of early correction of anemia on the progression of CKD.

Am J Kidney Dis 2006 May;47(5):738-50

Paris Descartes University, INSERM U652, AP-HP, Georges Pompidou European Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2006.02.170DOI Listing
May 2006

Assessment of the bioequivalence of a generic cyclosporine A by a randomized controlled trial in stable renal recipients.

Transplantation 2006 Mar;81(5):711-7

Newcastle Transplant Unit, Division of Surgery, John Hunter Hospital, Newcastle, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.tp.0000181198.98232.0cDOI Listing
March 2006

Fistula dysfunction secondary to a subcutaneous myelomatous deposit.

Nephrol Dial Transplant 2005 Dec 26;20(12):2827-9. Epub 2005 Jul 26.

Department of Radiology, Westmead Hospital, Sydney, NSW 2031, Australia.

View Article

Download full-text PDF

Source
http://academic.oup.com/ndt/article/20/12/2827/1924354/Fistu
Publisher Site
http://dx.doi.org/10.1093/ndt/gfi034DOI Listing
December 2005

Rabeprazole-induced acute interstitial nephritis.

Nephrology (Carlton) 2005 Feb;10(1):7-9

University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1797.2005.00365.xDOI Listing
February 2005

What is the practical conversion dose when changing from epoetin alfa to darbepoetin outside of clinical trials?

Nephrology (Carlton) 2004 Aug;9(4):223-8

Department of Renal Medicine, Gosford Hospital, Gosford, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1797.2004.00261.xDOI Listing
August 2004

Development, prevention, and potential reversal of left ventricular hypertrophy in chronic kidney disease.

J Am Soc Nephrol 2004 Jun;15(6):1640-7

Department of Nephrology, Western and Royal Melbourne Hospitals, Melbourne, Victoria 3050, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.asn.0000130566.69170.5eDOI Listing
June 2004